Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
Conditions
Advanced Breast Carcinoma · Advanced Endometrial Carcinoma · Advanced Fallopian Tube Carcinoma · Advanced Hepatocellular Carcinoma · Advanced Malignant Abdominal Neoplasm · Advanced Malignant Female Reproductive System Neoplasm · Advanced Malignant Thoracic Neoplasm · Advanced Ovarian Carcinoma · Advanced Primary Peritoneal Carcinoma · Advanced Renal Cell Carcinoma · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIB Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Malignant Abdominal Neoplasm · Malignant Solid Neoplasm · Metastatic Breast Carcinoma · Metastatic Endometrial Carcinoma · Metastatic Fallopian Tube Carcinoma · Metastatic Hepatocellular Carcinoma · Metastatic Malignant Abdominal Neoplasm · Metastatic Malignant Female Reproductive System Neoplasm · Metastatic Malignant Thoracic Neoplasm · Metastatic Ovarian Carcinoma · Metastatic Primary Peritoneal Carcinoma · Metastatic Renal Cell Carcinoma · Prognostic Stage III Breast Cancer AJCC v8 · Prognostic Stage IIIA Breast Cancer AJCC v8 · Prognostic Stage IIIB Breast Cancer AJCC v8 · Prognostic Stage IIIC Breast Cancer AJCC v8 · Prognostic Stage IV Breast Cancer AJCC v8 · Stage III Fallopian Tube Cancer AJCC v8 · Stage III Hepatocellular Carcinoma AJCC v8 · Stage III Ovarian Cancer AJCC v8 · Stage III Primary Peritoneal Cancer AJCC v8 · Stage III Renal Cell Cancer AJCC v8 · Stage III Uterine Corpus Cancer AJCC v8 · Stage IIIA Fallopian Tube Cancer AJCC v8 · Stage IIIA Hepatocellular Carcinoma AJCC v8 · Stage IIIA Ovarian Cancer AJCC v8 · Stage IIIA Primary Peritoneal Cancer AJCC v8 · Stage IIIA Uterine Corpus Cancer AJCC v8 · Stage IIIA1 Fallopian Tube Cancer AJCC v8 · Stage IIIA1 Ovarian Cancer AJCC v8 · Stage IIIA2 Fallopian Tube Cancer AJCC v8 · Stage IIIA2 Ovarian Cancer AJCC v8 · Stage IIIB Fallopian Tube Cancer AJCC v8 · Stage IIIB Hepatocellular Carcinoma AJCC v8 · Stage IIIB Ovarian Cancer AJCC v8 · Stage IIIB Primary Peritoneal Cancer AJCC v8 · Stage IIIB Uterine Corpus Cancer AJCC v8 · Stage IIIC Fallopian Tube Cancer AJCC v8 · Stage IIIC Ovarian Cancer AJCC v8 · Stage IIIC Primary Peritoneal Cancer AJCC v8 · Stage IIIC Uterine Corpus Cancer AJCC v8 · Stage IIIC1 Uterine Corpus Cancer AJCC v8 · Stage IIIC2 Uterine Corpus Cancer AJCC v8 · Stage IV Fallopian Tube Cancer AJCC v8 · Stage IV Hepatocellular Carcinoma AJCC v8 · Stage IV Ovarian Cancer AJCC v8 · Stage IV Primary Peritoneal Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8 · Stage IV Uterine Corpus Cancer AJCC v8 · Stage IVA Fallopian Tube Cancer AJCC v8 · Stage IVA Hepatocellular Carcinoma AJCC v8 · Stage IVA Ovarian Cancer AJCC v8 · Stage IVA Primary Peritoneal Cancer AJCC v8 · Stage IVA Uterine Corpus Cancer AJCC v8 · Stage IVB Fallopian Tube Cancer AJCC v8 · Stage IVB Hepatocellular Carcinoma AJCC v8 · Stage IVB Ovarian Cancer AJCC v8 · Stage IVB Primary Peritoneal Cancer AJCC v8 · Stage IVB Uterine Corpus Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Apostolia M. Tsimberidou)
Study leads
Apostolia M Tsimberidou
Principal Investigator
M.D. Anderson Cancer Center